Kevin McCulloch, President and Chief Operating Officer of Xeris Biopharma Holdings, Inc., filed a Form 4 on September 1, 2026, disclosing the sale of 15,000 shares of common stock pursuant to a previously adopted Rule 10b5-1 trading plan.
A Form 4 filed with the SEC on September 1, 2026, discloses that Andy Dignan, President of Five9, Inc. (NASDAQ:FIVN), sold 17,767 shares of common stock on August 28, 2026, pursuant to a pre-established Rule 10b5-1 trading plan.
A Form 4 filed with the SEC on September 1, 2026, discloses that Michael George Rosenbaum, Chief Executive Officer and Director of Guidewire Software, Inc. (NYSE:GWRE), sold 1,200 shares of common stock on August 31, 2026, pursuant to a pre-established 10b5-1 trading plan.
A Form 4 filed on September 1, 2026, discloses that Satya Nadella, Chief Executive Officer and Director of Microsoft Corp (NASDAQ:MSFT), acquired 178,622 shares of common stock through a performance stock award vesting on August 31, 2026, and had 70,465.844 shares withheld for taxes …
A Form 4 filed on September 1, 2026 with the SEC discloses that Takeshi Numoto, Executive Vice President and Chief Marketing Officer of Microsoft Corp (NASDAQ:MSFT), reported the vesting of a performance stock award and a related tax withholding disposition of common stock on …
Bradford L. Smith, Vice Chair and President of Microsoft Corp (NASDAQ:MSFT), filed a Form 4 on September 1, 2026, disclosing transactions in Microsoft common stock dated August 31, 2026.
Derek J. Maetzold, President and Chief Executive Officer of Castle Biosciences Inc., filed a Form 4 on September 1, 2026, disclosing stock option exercises and common stock sales executed on August 28, 2026, under a pre-established Rule 10b5-1 trading plan.
Rajendra K Talluri, CEO and Director of Kulicke & Soffa Industries Inc, filed a Form 4 on September 1, 2026, reporting the acquisition of 89,697 shares of common stock at no cost under the company's 2021 Omnibus Incentive Plan.
Danny Gilad Allouche, President of the Materials Group at Avery Dennison Corp (NYSE:AVY), filed a Form 4 on September 1, 2026, reporting the acquisition of three equity awards granted on September 1, 2026.
A Form 4 filed on September 1, 2026, discloses that William Raymond Wagner, a director of Avery Dennison Corp (NYSE:AVY), received a supplemental restricted stock unit award in connection with his election as independent Board Chair.